PDS Biotechnology CorporationPDSBNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-36.32M
Near historical average
Average (9y)
$-33.40M
Historical baseline
Range
High:$-14.90M
Low:$-51.97M
CAGR
+3.6%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-36.32M | +15.6% |
| 2023 | $-43.05M | -3.3% |
| 2022 | $-41.67M | -94.4% |
| 2021 | $-21.44M | -43.9% |
| 2020 | $-14.90M | +3.9% |
| 2019 | $-15.51M | +64.0% |
| 2018 | $-43.10M | +17.1% |
| 2017 | $-51.97M | -31.5% |
| 2016 | $-39.51M | -49.1% |
| 2015 | $-26.50M | - |